Teleflex Incorporated (NYSE:TFX) Shares Acquired by Ieq Capital LLC

Ieq Capital LLC boosted its holdings in Teleflex Incorporated (NYSE:TFX) by 178.2% during the fourth quarter, HoldingsChannel reports. The fund owned 12,890 shares of the medical technology company’s stock after buying an additional 8,257 shares during the period. Ieq Capital LLC’s holdings in Teleflex were worth $2,294,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in TFX. Apollon Wealth Management LLC lifted its stake in shares of Teleflex by 3.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after purchasing an additional 55 shares during the last quarter. SRS Capital Advisors Inc. boosted its stake in Teleflex by 0.3% during the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock worth $4,844,000 after buying an additional 60 shares during the period. Janney Montgomery Scott LLC raised its stake in shares of Teleflex by 0.4% in the 3rd quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock valued at $3,792,000 after acquiring an additional 65 shares during the period. Tokio Marine Asset Management Co. Ltd. lifted its holdings in shares of Teleflex by 4.5% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock worth $375,000 after acquiring an additional 66 shares during the last quarter. Finally, HighTower Advisors LLC increased its holdings in Teleflex by 1.7% in the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after purchasing an additional 66 shares during the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

TFX has been the subject of several research reports. Royal Bank of Canada dropped their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Truist Financial cut their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Mizuho decreased their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $246.00.

Teleflex Stock Performance

NYSE:TFX opened at $175.43 on Monday. Teleflex Incorporated has a 12 month low of $165.62 and a 12 month high of $249.90. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The firm has a market capitalization of $8.15 billion, a PE ratio of 34.88, a price-to-earnings-growth ratio of 1.73 and a beta of 1.16. The business’s fifty day moving average price is $176.98 and its 200 day moving average price is $207.23.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.